Pitfalls and Limitations of Radionuclide and Hybrid Imaging in Infection and Inflammation

Seminars in Nuclear Medicine

Volumn 45, Issue 6, 2015, Pages 500-512

  Glaudemans, Andor W J M ^a   Israel, Ora ^b   Slart, Riemer H J A ^a,c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM 68; RADIOISOTOPE; CONTRAST MEDIUM; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CARDIOVASCULAR INFECTION; CELL LABELING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HYBRID; INFECTION; INFLAMMATION; LEUKOCYTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PYREXIA IDIOPATHICA; SCINTIGRAPHY; TREATMENT RESPONSE; VASCULITIS; WBC SCINTIGRAPHY; ENDOCARDITIS; MULTIMODAL IMAGING; MUSCULOSKELETAL DISEASE; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RADIOGRAPHY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CONTRAST MEDIA; ENDOCARDITIS; FEVER OF UNKNOWN ORIGIN; FLUORODEOXYGLUCOSE F18; HUMANS; INFECTION; INFLAMMATION; LEUKOCYTES; MAGNETIC RESONANCE IMAGING; MULTIMODAL IMAGING; MUSCULOSKELETAL DISEASES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; VASCULITIS;

EID: 84945897182     PISSN: 00012998     EISSN: 15584623     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2015.02.005     Document Type: Review

References (70)

1. 99mTc-HMPAO Eur J Nucl Med Mol Imaging 37 4 2010 842 848
2. 111In-oxine Eur J Nucl Med Mol Imaging 37 4 2010 835 841
3. A.W. Glaudemans, F. Galli, M. Pacilio, and et al. Leukocyte and bacteria imaging in prosthetic joint infection Eur Cell Mater 25 2013 61 77
4. 99mTc-labelled white blood cell scintigraphic images Nucl Med Commun 29 12 2008 1093 1099
5. 99mTc-HMPAO-labelled white blood cell scintigraphy: Results of a multicentre study Eur J Nucl Med Mol Imaging 41 4 2014 615 623
6. 99mTc-HMPAO-labelled leucocytes in musculoskeletal infections Eur J Nucl Med Mol Imaging 40 11 2013 1760 1769
7. F.R. Grippaudo, M. Pacilio, G.M. Di, and et al. Radiolabelled white blood cell scintigraphy in the work-up of dermal filler complications Eur J Nucl Med Mol Imaging 40 3 2013 418 425
8. 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis J Nucl Med 53 8 2012 1235 1243
9. O. Schillaci Hybrid imaging systems in the diagnosis of osteomyelitis and prosthetic joint infection Q J Nucl Med Mol Imaging 53 1 2009 95 104
10. 18F-FDG PET/CT 1.0 J Nucl Med 47 5 2006 885 895
11. R. Boellaard, M.J. Doherty, W.A. Weber, and et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: Version 1.0 Eur J Nucl Med Mol Imaging 37 1 2010 181 200
12. K.J. Langen, U. Braun, K.E. Rota, and et al. The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas J Nucl Med 34 3 1993 355 359
13. 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A Comparative analysis J Nucl Med 51 7 2010 1015 1020
14. 18F-FDG use in inflammation and infection J Nucl Med 54 4 2013 647 658
15. 18F]-fluoro-D-glucose positron emission tomography (FDG-PET) in an animal model J Orthop Res 23 6 2005 1484 1489
16. H. Zhuang, J.W. Sam, T.K. Chacko, and et al. Rapid normalization of osseous FDG uptake following traumatic or surgical fractures Eur J Nucl Med Mol Imaging 30 8 2003 1096 1103
17. 18F-FDG PET: Age dependency and frequency after chemotherapy J Nucl Med 42 4 2001 591 595
18. B.A. Bell, D.W. Esseltine, and E.M. Azouz Rebound thymic hyperplasia in a child with cancer Med Pediatr Oncol 12 2 1984 144 147
19. F. Pagliai, L. Rigacci, V. Briganti, and et al. PET scan evaluation of thymic mass after autologous peripheral blood stem-cell transplantation in an adult with non-Hodgkin's lymphoma Leuk Lymphoma 44 11 2003 2015 2018
20. 18F-FDG in children and young adults: A PET/CT evaluation of incidence, patterns, and relationship to treatment J Nucl Med 50 6 2009 849 853
21. N. Berliner Leukopenia and leukocytosis L. Goldman, A.L. Schafer, Cecil Medicine 2011 Saunders Elsevier Philadelphia
22. F.L. Datz, and D.A. Thorne Effect of antibiotic therapy on the sensitivity of indium-111-labeled leukocyte scans J Nucl Med 27 12 1986 1849 1853
23. 18F-FDG bowel uptake in patients treated with metformin Eur J Nucl Med Mol Imaging. 35 1 2008 95 99
24. 18F-FDG PET/CT uptake Presse Med 38 4 2009 686 687
25. J.R. Oh, H.C. Song, A. Chong, and et al. Impact of medication discontinuation on increased intestinal FDG accumulation in diabetic patients treated with metformin AJR Am J Roentgenol 195 6 2010 1404 1410
26. A. Lyall, H.A. Vargas, R.D. Carvajal, and et al. Ipilimumab-induced colitis on FDG PET/CT Clin Nucl Med 37 6 2012 629 630
27. N.M. Long, and C.S. Smith Causes and imaging features of false positives and false negatives on F-PET/CT in oncologic imaging Insights Imaging 2 6 2011 679 698
28. G. Antoch, L.S. Freudenberg, T. Egelhof, and et al. Focal tracer uptake: A potential artifact in contrast-enhanced dual-modality PET/CT scans J Nucl Med 43 10 2002 1339 1342
29. C. Cohade, M. Osman, Y. Nakamoto, and et al. Initial experience with oral contrast in PET/CT: Phantom and clinical studies J Nucl Med 44 2003 412 416
30. E. Dizendorf, T.F. Hany, A. Buck, and et al. Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies J Nucl Med 44 5 2003 732 738
31. W. Sureshbabu, and O. Mawlawi PET/CT imaging artifacts J Nucl Med Technol 33 3 2005 156 161
32. 18F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases Clin Dev Immunol 2013 2013 623036
33. 18FDG PET: Illusion or reality? A critical review of the literature data Eur J Nucl Med Mol Imaging 30 9 2003 1305 1313
34. 18F-FDG PET/CT case-control study Eur J Nucl Med Mol Imaging 41 1 2014 155 166
35. 18F-FDG PET: Introducing an ROC-analysis-based cutoff ratio J Nucl Med 49 7 2008 1107 1113
36. 18F]FDG PET and MRI Eur J Nucl Med Mol Imaging 30 5 2003 730 736
37. S. Prieto-Gonzalez, M. Depetris, A. Garcia-Martinez, and et al. Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: A prospective, case-control study Ann Rheum Dis 73 7 2014 1388 1392
38. C. Mukhtyar, L. Guillevin, M.C. Cid, and et al. EULAR recommendations for the management of large vessel vasculitis Ann Rheum Dis 68 3 2009 318 323
39. 18F-FDG PET on the management of patients with suspected large vessel vasculitis Eur J Nucl Med Mol Imaging 39 2 2012 344 353
40. A. Clifford, S. Burrell, and J.G. Hanly Positron emission tomography/computed tomography for the diagnosis and assessment of giant cell arteritis: When to consider it and why J Rheumatol 39 10 2012 1909 1911
41. 18F-FDG myocardial uptake using a fat-allowed, carbohydrate-restricted diet J Nucl Med Technol 39 3 2011 185 189
42. 18F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet J Cardiol 62 5 2013 314 319
43. 18F-FDG PET/CT in diagnosing infectious endocarditis Eur J Nucl Med Mol Imaging 40 7 2013 1102 1107
44. M. Soussan, P.Y. Brillet, H. Nunes, and et al. Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis J Nucl Cardiol 20 1 2013 120 127
45. Z. Keidar, and S. Nitecki FDG-PET in prosthetic graft infections Semin Nucl Med 43 5 2013 396 402
46. 18F-FDG uptake in noninfected prosthetic vascular grafts: Incidence, patterns, and changes over time J Nucl Med 55 3 2014 392 395
47. P.A. Erba, G. Leo, M. Sollini, and et al. Radiolabelled leucocyte scintigraphy versus conventional radiological imaging for the management of late, low-grade vascular prosthesis infections Eur J Nucl Med Mol Imaging 41 2 2014 357 368
48. A. Signore, and A.W. Glaudemans The molecular imaging approach to image infections and inflammation by nuclear medicine techniques Ann Nucl Med 25 10 2011 681 700
49. D.L. Goldenberg Septic arthritis Lancet 351 9097 1998 197 202
50. 99mTc-white blood cell and bone imaging improves the diagnostic accuracy in the detection of hip replacement infections Eur J Nucl Med 28 3 2001 288 293
51. A.W. Glaudemans, and A. Signore FDG-PET/CT in infections: The imaging method of choice? Eur J Nucl Med Mol Imaging 37 10 2010 1986 1991
52. G.W. Goerres, S.I. Ziegler, C. Burger, and et al. Artifacts at PET and PET/CT caused by metallic hip prosthetic material Radiology 226 2 2003 577 584
53. P. Reinartz, T. Mumme, B. Hermanns, and et al. Radionuclide imaging of the painful hip arthroplasty: Positron-emission tomography versus triple-phase bone scanning J Bone Joint Surg Br 87 4 2005 465 470
54. 18F-FDG PET/CT J Nucl Med 47 8 2006 1274 1280
55. S. Basu, T. Chryssikos, M. Houseni, and et al. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: Can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection? Nucl Med Commun 28 6 2007 465 472
56. O. Kagna, S. Srour, E. Melamed, and et al. FDG PET/CT imaging in the diagnosis of osteomyelitis in the diabetic foot Eur J Nucl Med Mol Imaging 39 10 2012 1545 1550
57. 18F-FDG PET/CT J Nucl Med 46 3 2005 444 449
58. 18F-FDG PET/CT replace WBC imaging in the diabetic foot? J Nucl Med 52 7 2011 1012 1019
59. S.P. Rowe, and S.Y. Cho The role of PET in the evaluation of musculoskeletal infections Semin Musculoskelet Radiol 18 2 2014 166 174
60. C.P. Bleeker-Rovers, F.J. Vos, A.H. Mudde, and et al. A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin Eur J Nucl Med Mol Imaging 34 5 2007 694 703
61. 18F-FDG-PET with computed tomography in the diagnostic algorithm of patients with fever of unknown origin Eur J Clin Microbiol Infect Dis 31 8 2012 1727 1733
62. A.W. Glaudemans, A.M. Quintero, and A. Signore PET/MRI in infectious and inflammatory diseases: Will it be a useful improvement? Eur J Nucl Med Mol Imaging 39 5 2012 745 749
63. O. Schillaci Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity Semin Nucl Med 42 4 2012 267 280
64. S.T. Lee, and A.M. Scott Are we ready for dual-time point FDG PET imaging? J Med Imaging Radiat Oncol 55 4 2011 351 352
65. G. Cheng, D.A. Torigian, H. Zhuang, and et al. When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET? Eur J Nucl Med Mol Imaging 40 5 2013 779 787
66. H.J. van den, A. Lougovski, G. Schramm, and et al. Correction of scan time dependence of standard uptake values in oncological PET Eur J Nucl Med Mol Imaging Res 4 1 2014 18
67. 18F-FDG-labeled leukocyte PET/CT: Initial experience in 21 patients J Nucl Med 47 4 2006 625 632
68. 18F-FDG-labeled leukocytes Q J Nucl Med Mol Imaging 50 2 2006 143 146
69. 18F-FDG Nucl Med Biol 36 5 2009 545 549
70. 68Ga-citrate PET/CT for evaluating patients with infections of the bone: Preliminary results J Nucl Med 51 12 2010 1932 1936